Finance

Lists
SNW:ETR
Sanofi SA
71,57 €
-0,07%
(-0,050) 1D
12 հոկ, 17:35:48 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for SNW...
Open
71,93 €
High
72,18 €
Low
71,53 €
Mkt. cap
86,54 մլրդ
Avg. vol.
14,08 հզր
Volume
11,41 հզր
P/E ratio
21,95
52-wk high
90,75 €
52-wk low
69,77 €
EPS
3,26 €
Shares outstanding
1,25 մլրդ
No. of employees
75 հզր
Open
71,93 €
High
72,18 €
Low
71,53 €
Mkt. cap
86,54 մլրդ
Avg. vol.
14,08 հզր
Volume
11,41 հզր
P/E ratio
21,95
52-wk high
90,75 €
52-wk low
69,77 €
EPS
3,26 €
Shares outstanding
1,25 մլրդ
No. of employees
75 հզր
News stories
From web sources and news partners
Profile
Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris. The corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis, which were each the product of several previous mergers. It changed its name back to Sanofi in May 2011. The company trades as "SAN" on Euronext Paris and "SNY" on Nasdaq in the United States, and is a component of the Euro Stoxx 50 stock market index. In 2023, the company was ranked 89th in the Forbes Global 2000. Sanofi engages in the research and development, manufacturing, and marketing of pharmacological products, principally in the prescription market, but the firm also develops over-the-counter medications. The corporation covers seven major therapeutic areas: cardiovascular, central nervous system, diabetes, internal medicine, oncology, thrombosis, and vaccines. It is one of the world's largest producer of vaccines through its subsidiary Sanofi Pasteur. Wikipedia
About Sanofi SA
CEOPaul Hudson | Belén Garijo
Employees74,8 հզր
Founded1973
HeadquartersՓարիզ, Իլ դը Ֆրանս, Ֆրանսիա
Sector-
Websitesanofi.com
Last report
30 հլս, 2026 թ.
Fiscal period
Q2 2026
- / 1,90 €
Revenue / Est. (EUR)
12,30 մլրդ / 10,89 մլրդ
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
13,17 մլրդ
12,20 մլրդ
11,24 մլրդ
12,30 մլրդ
Cost of goods sold
3,41 մլրդ
3,63 մլրդ
3,06 մլրդ
2,89 մլրդ
Cost of revenue
3,41 մլրդ
3,63 մլրդ
3,06 մլրդ
2,89 մլրդ
Research and development expenses
1,83 մլրդ
2,29 մլրդ
1,75 մլրդ
2,23 մլրդ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,29 մլրդ
2,82 մլրդ
2,33 մլրդ
2,49 մլրդ
Operating expense
5,97 մլրդ
6,84 մլրդ
5,94 մլրդ
6,82 մլրդ
Total operating expenses
9,39 մլրդ
10,46 մլրդ
9,00 մլրդ
9,71 մլրդ
Operating income
3,78 մլրդ
1,74 մլրդ
2,25 մլրդ
2,59 մլրդ
Other non operating income
-
122,00 մլն
-40,00 մլն
-91,00 մլն
EBT including unusual items
3,51 մլրդ
-1,16 մլրդ
2,01 մլրդ
828,00 մլն
EBT excluding unusual items
3,67 մլրդ
1,70 մլրդ
2,14 մլրդ
2,40 մլրդ
Income tax expense
680,00 մլն
-348,00 մլն
420,00 մլն
451,00 մլն
Effective tax rate
19,38%
30,13%
20,85%
54,47%
Other operating expenses
1,39 մլրդ
1,19 մլրդ
1,33 մլրդ
1,55 մլրդ
Net income
2,80 մլրդ
-801,00 մլն
1,61 մլրդ
343,00 մլն
Net profit margin
21,28%
-6,56%
14,35%
2,79%
Earnings per share
-
1,53
1,88
-
Interest and investment income
114,00 մլն
79,00 մլն
60,00 մլն
64,00 մլն
Interest expense
-227,00 մլն
-
-138,00 մլն
-153,00 մլն
Net interest expenses
-113,00 մլն
79,00 մլն
-78,00 մլն
-89,00 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
4,20 մլրդ
3,49 մլրդ
2,78 մլրդ
3,83 մլրդ
Gain or loss from assets sale
266,00 մլն
-79,00 մլն
-
-9,00 մլն
AI content may include mistakes. Learn more
Google Apps